228 related articles for article (PubMed ID: 27545489)
1. First US experience following FDA approval of the ABBOTT vascular bioresorbable vascular scaffold for the treatment of coronary artery disease.
Rizik DG; Shah MG; Burke RF
Catheter Cardiovasc Interv; 2016 Nov; 88(6):899-901. PubMed ID: 27545489
[TBL] [Abstract][Full Text] [Related]
2. Early U.S. Experience Following FDA Approval of the ABBOTT Vascular Bioresorbable Vascular Scaffold: Optimal Deployment Technique Using High Resolution Coronary Artery Imaging.
Rizik DG; Padaliya BB
J Interv Cardiol; 2016 Oct; 29(5):546-548. PubMed ID: 27492571
[TBL] [Abstract][Full Text] [Related]
3. No more metallic cages: an attractive hybrid strategy with bioresorbable vascular scaffold and drug-eluting balloon for diffuse or tandem lesions in the same vessel.
Naganuma T; Latib A; Ielasi A; Panoulas VF; Sato K; Miyazaki T; Colombo A
Int J Cardiol; 2014 Apr; 172(3):618-9. PubMed ID: 24495653
[No Abstract] [Full Text] [Related]
4. Lumen gain and restoration of pulsatility after implantation of a bioresorbable vascular scaffold in porcine coronary arteries.
Lane JP; Perkins LE; Sheehy AJ; Pacheco EJ; Frie MP; Lambert BJ; Rapoza RJ; Virmani R
JACC Cardiovasc Interv; 2014 Jun; 7(6):688-95. PubMed ID: 24835327
[TBL] [Abstract][Full Text] [Related]
5. Complex bifurcation lesions: Randomized comparison of a fully bioresorbable modified t stenting strategy versus bifurcation reconstruction with a dedicated self-expanding stent in combination with bioresorbable scaffolds, an OCT study: Rationale and design of the COBRA II trial.
Bennett J; Adriaenssens T; Desmet W; Dubois C
Catheter Cardiovasc Interv; 2016 Nov; 88(6):843-853. PubMed ID: 27184586
[TBL] [Abstract][Full Text] [Related]
6. First reported use of drug-coated balloon for bioresorbable in-scaffold restenosis.
Latini RA; Buccheri D; Cortese B
Catheter Cardiovasc Interv; 2017 Mar; 89(4):676-678. PubMed ID: 27649683
[TBL] [Abstract][Full Text] [Related]
7. Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus-Eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
Onuma Y; Serruys PW; Muramatsu T; Nakatani S; van Geuns RJ; de Bruyne B; Dudek D; Christiansen E; Smits PC; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Garcia-Garcia HM; Veldhof S; Rapoza R; Ormiston JA
JACC Cardiovasc Interv; 2014 Dec; 7(12):1400-11. PubMed ID: 25523532
[TBL] [Abstract][Full Text] [Related]
8. Bioresorbable vascular scaffolds for the treatment of coronary artery disease: Clinical outcomes from randomized controlled trials.
Rizik DG; Hermiller JB; Kereiakes DJ
Catheter Cardiovasc Interv; 2016 Nov; 88(S1):21-30. PubMed ID: 27797464
[TBL] [Abstract][Full Text] [Related]
9. Footprint of a Bioresorbable Vascular Scaffold in Computed Tomography Coronary Angiogram at 5-Year Follow-up.
Vijayvergiya R; Kanabar K; Palanivel R; Lal A; Gupta A
J Invasive Cardiol; 2020 May; 32(5):E136-E137. PubMed ID: 32357136
[TBL] [Abstract][Full Text] [Related]
10. Computed tomography angiography for guiding and follow-up of magnesium-bioresorbable scaffold implantation.
Opolski MP; Kepka C; Wojakowski W; Witkowski A
Clin Res Cardiol; 2019 Mar; 108(3):344-346. PubMed ID: 30182164
[No Abstract] [Full Text] [Related]
11. Dislodgement of a magnesium bioresorbable scaffold from the delivery system in the left main: A true "nightmaris".
Cortés C; Jaguszewski M; Schincariol M; Durán-Cortés MA; Limon U; Gutiérrez-Chico JL
Cardiol J; 2017; 24(6):700-701. PubMed ID: 29297580
[No Abstract] [Full Text] [Related]
12. Evaluation of a fully bioresorbable vascular scaffold in patients with coronary artery disease: design of and rationale for the ABSORB III randomized trial.
Kereiakes DJ; Ellis SG; Popma JJ; Fitzgerald PJ; Samady H; Jones-McMeans J; Zhang Z; Cheong WF; Su X; Ben-Yehuda O; Stone GW
Am Heart J; 2015 Oct; 170(4):641-651.e3. PubMed ID: 26386787
[TBL] [Abstract][Full Text] [Related]
13. Bioresorbable vascular scaffold thrombosis in a consecutive cohort of 550 patients.
Tröbs M; Achenbach S; Röther J; Klinghammer L; Schlundt C
Catheter Cardiovasc Interv; 2016 Nov; 88(6):872-880. PubMed ID: 27142643
[TBL] [Abstract][Full Text] [Related]
14. In-scaffold restenosis in a previous left main bifurcation lesion treated with bioresorbable scaffold v-stenting.
Miyazaki T; Panoulas VF; Sato K; Kawamoto H; Naganuma T; Latib A; Colombo A
JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt A):e7-e10. PubMed ID: 25499306
[No Abstract] [Full Text] [Related]
15. Expansion in calcific lesions and overall clinical outcomes following bioresorbable scaffold implantation optimized with intravascular ultrasound.
Kawamoto H; Ruparelia N; Latib A; Miyazaki T; Sato K; Tanaka A; Naganuma T; Sticchi A; Chieffo A; Carlino M; Montorfano M; Colombo A
Catheter Cardiovasc Interv; 2017 Apr; 89(5):789-797. PubMed ID: 27545845
[TBL] [Abstract][Full Text] [Related]
16. Treading the risky ground of coronary bifurcation lesion revascularization, the "biodegradable strategy" may represent the lifeline.
Piraino D; Buccheri D; Andolina G
Int J Cardiol; 2016 Oct; 221():577-80. PubMed ID: 27420582
[No Abstract] [Full Text] [Related]
17. ABSORB biodegradable stents versus second-generation metal stents: a comparison study of 100 complex lesions treated under OCT guidance.
Mattesini A; Secco GG; Dall'Ara G; Ghione M; Rama-Merchan JC; Lupi A; Viceconte N; Lindsay AC; De Silva R; Foin N; Naganuma T; Valente S; Colombo A; Di Mario C
JACC Cardiovasc Interv; 2014 Jul; 7(7):741-50. PubMed ID: 25060016
[TBL] [Abstract][Full Text] [Related]
18. Rotational Atherectomy Combined With Bioresorbable Vascular Scaffold Implantation: A Feasible Approach for Recurrent In-stent Restenosis When Other Therapies Failed.
Pereira-da-Silva T; Patrício L; Cruz Ferreira R
J Invasive Cardiol; 2015 Jul; 27(7):E143-5. PubMed ID: 26136289
[TBL] [Abstract][Full Text] [Related]
19. A true bifurcational stenosis treated with a bioresorbable vascular scaffold and a drug-eluting metallic stent: Degradable meets durable.
Wiebe J; Hamm C; Nef H
Catheter Cardiovasc Interv; 2015 Jun; 85(7):1184-8. PubMed ID: 25581885
[TBL] [Abstract][Full Text] [Related]
20. Comparison of early clinical outcomes between ABSORB bioresorbable vascular scaffold and everolimus-eluting stent implantation in a real-world population.
Costopoulos C; Latib A; Naganuma T; Miyazaki T; Sato K; Figini F; Sticchi A; Carlino M; Chieffo A; Montorfano M; Colombo A
Catheter Cardiovasc Interv; 2015 Jan; 85(1):E10-5. PubMed ID: 24909303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
